Focus on the "2021 Gusu Dialogue" - Facilitating Medical Innovation and Integrating into the Era of Change

2021Gusu Dialogue is themed "Innovation, Future, Globalization", focusing on hot topics in the pharmaceutical industry, focusing on cutting-edge innovation in the industry, and gathering industry wisdom and strength. Authoritative experts, senior scholars and leading companies at home and abroad will bring 22 special forums and more than 100 wonderful speeches. A total of 2,000 representatives including leaders of relevant national regulatory departments, experts from testing institutions, industry technology masters, and CEOs of pharmaceutical companies will attend the meeting.

2021Suzhou Dialogue facilitates face-to-face communication between innovative drugs and innovative packaging/delivery devices. At the same time, a special session on "Bio, Innovation, and the Future" was added, focusing on hot areas such as CAR-T therapy, progress in clinical trials of new crown vaccines, new molecules of monoclonal antibody drugs, and gene therapy. Well-known experts in the field of biological innovation were invited to share topics related to biological innovation and the future.

Dr. Zhang Chenghai, CEO of Shanghai Maiji Biotechnology Co., Ltd., was invited to attend the conference and gave a report on the theme of "Discovery and application value of new molecules of monoclonal antibody drugs". As the founder of Maiji Biopharma, Dr. Zhang Chenghai focused on the research progress of the company's first blockbuster product, MG-K10, in his report, combining the pipeline layout of Maiji products. Based on the good performance of the product and its broad market prospects, the company will accelerate the launch of the product to benefit patients as soon as possible.

Dr. Zhang Chenghai gave a keynote speech at the conference

Chairman of the sub-forum Fang Yi presented a certificate to Dr. Zhang Chenghai